Antitumor Effect of Low-Dose of Rapamycin in a Transgenic Mouse Model of Liver Cancer.
Hyung Soon LeeJoon Ye KimSimon Weonsang RoMyoung Soo KimHaeryoung KimDong Jin JooPublished in: Yonsei medical journal (2022)
Low-dose rapamycin might be effective to prevent HCC growth, but may be ineffective as a treatment option after HCC development.